KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Operating Leases (2019 - 2025)

Historic Operating Leases for CareDx (CDNA) over the last 7 years, with Q3 2025 value amounting to $27.6 million.

  • CareDx's Operating Leases fell 774.57% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year decrease of 774.57%. This contributed to the annual value of $22.3 million for FY2024, which is 2127.1% down from last year.
  • Latest data reveals that CareDx reported Operating Leases of $27.6 million as of Q3 2025, which was down 774.57% from $29.1 million recorded in Q2 2025.
  • Over the past 5 years, CareDx's Operating Leases peaked at $39.9 million during Q3 2022, and registered a low of $17.4 million during Q4 2021.
  • Its 5-year average for Operating Leases is $28.2 million, with a median of $29.1 million in 2025.
  • In the last 5 years, CareDx's Operating Leases surged by 9205.47% in 2022 and then crashed by 2127.1% in 2024.
  • Over the past 5 years, CareDx's Operating Leases (Quarter) stood at $17.4 million in 2021, then surged by 92.05% to $33.4 million in 2022, then decreased by 15.35% to $28.3 million in 2023, then dropped by 21.27% to $22.3 million in 2024, then grew by 24.17% to $27.6 million in 2025.
  • Its Operating Leases stands at $27.6 million for Q3 2025, versus $29.1 million for Q2 2025 and $30.3 million for Q1 2025.